WP 1075
Alternative Names: Cat dander allergy immunotherapy - Worg Pharmaceuticals; WP-1075Latest Information Update: 19 Feb 2022
At a glance
- Originator Biomay
- Developer Worg Pharmaceuticals (Hangzhou)
- Class Antiallergics; Cat allergy immunotherapies; Peptide vaccines; Recombinant fusion proteins
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hypersensitivity